tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Shield Therapeutics’ ACCRUFeR® Receives FDA Priority Review for Pediatric Use
Company AnnouncementsShield Therapeutics’ ACCRUFeR® Receives FDA Priority Review for Pediatric Use
7h ago
Shield Therapeutics Reports Strong H1 2025 Results and Global Expansion
PremiumCompany Announcements
Shield Therapeutics Reports Strong H1 2025 Results and Global Expansion
24h ago
Shield Therapeutics Reports Positive Results for Ferric Maltol in Heart Failure Patients
PremiumCompany Announcements
Shield Therapeutics Reports Positive Results for Ferric Maltol in Heart Failure Patients
8d ago
Shield Therapeutics Reports Strong H1 2025 Results and Global Expansion
PremiumCompany Announcements
Shield Therapeutics Reports Strong H1 2025 Results and Global Expansion
14d ago
Shield Therapeutics Doubles ACCRUFeR® Revenues in Q2 2025
PremiumCompany Announcements
Shield Therapeutics Doubles ACCRUFeR® Revenues in Q2 2025
1M ago
Shield Therapeutics Secures Shareholder Support at 2025 AGM
PremiumCompany AnnouncementsShield Therapeutics Secures Shareholder Support at 2025 AGM
3M ago
Shield Therapeutics Reports Strong 2024 Financial Growth and Global Expansion of ACCRUFeR®
Premium
Company Announcements
Shield Therapeutics Reports Strong 2024 Financial Growth and Global Expansion of ACCRUFeR®
4M ago
Shield Therapeutics Partners with VITAL-NET for ACCRUFeR® Launch in Japan
Premium
Company Announcements
Shield Therapeutics Partners with VITAL-NET for ACCRUFeR® Launch in Japan
5M ago
Shield Therapeutics Reports Q1 2025 Revenue Growth and Strategic Progress
PremiumCompany Announcements
Shield Therapeutics Reports Q1 2025 Revenue Growth and Strategic Progress
5M ago
Shield Therapeutics Launches ACCRUFeR® in Canada to Address Iron Deficiency Anemia
PremiumCompany Announcements
Shield Therapeutics Launches ACCRUFeR® in Canada to Address Iron Deficiency Anemia
6M ago
Cautious Hold Rating on Shield Therapeutics Amidst Positive Financials and Prescription Growth Concerns
PremiumRatings
Cautious Hold Rating on Shield Therapeutics Amidst Positive Financials and Prescription Growth Concerns
7M ago
Shield Therapeutics CEO Increases Stake, Signaling Confidence in Company’s Strategic Direction
PremiumCompany Announcements
Shield Therapeutics CEO Increases Stake, Signaling Confidence in Company’s Strategic Direction
7M ago
Shield Therapeutics Grants Share Options to New CEO to Strengthen Market Position
PremiumCompany AnnouncementsShield Therapeutics Grants Share Options to New CEO to Strengthen Market Position
7M ago
Shield Therapeutics Hold Rating: Balancing Revenue Growth with Prescription Challenges and Financial Uncertainty
Premium
Ratings
Shield Therapeutics Hold Rating: Balancing Revenue Growth with Prescription Challenges and Financial Uncertainty
7M ago
Shield Therapeutics Sees Revenue Surge Amid Strategic Initiatives
Premium
Company Announcements
Shield Therapeutics Sees Revenue Surge Amid Strategic Initiatives
7M ago
Shield Therapeutics Appoints Anders Lundstrom as Permanent CEO
PremiumCompany Announcements
Shield Therapeutics Appoints Anders Lundstrom as Permanent CEO
7M ago
Shield Therapeutics Secures $10 Million Funding and Expands Share Capital
PremiumCompany Announcements
Shield Therapeutics Secures $10 Million Funding and Expands Share Capital
8M ago
Shield Therapeutics Raises Funds through RetailBook Offer
PremiumCompany Announcements
Shield Therapeutics Raises Funds through RetailBook Offer
9M ago
Shield Therapeutics Announces New RetailBook Share Offer
PremiumCompany Announcements
Shield Therapeutics Announces New RetailBook Share Offer
9M ago
Shield Therapeutics Aims for Financial Boost through Share Subscription
PremiumCompany AnnouncementsShield Therapeutics Aims for Financial Boost through Share Subscription
9M ago
Shield Therapeutics Reports Strong ACCRUFeR® Sales and Study Progress
Premium
Company Announcements
Shield Therapeutics Reports Strong ACCRUFeR® Sales and Study Progress
10M ago
Shield Therapeutics Sees Revenue Surge and Financial Boost
Premium
Company Announcements
Shield Therapeutics Sees Revenue Surge and Financial Boost
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >